Enanta Pharmaceuticals, Inc . (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in two investor conferences being webcast in May: JMP Securities Life Sciences Conference: Fireside Chat at 9:30 a.m. ET on May 16, 2023 RBC Capital Markets Global Healthcare Conference: Fireside Chat at 2:05 p.m. ET on May 17, 2023 A live webcast of...